PerkinElmer's bead-based AlphaLISA ® immunoassays are designed for the detection of analytes in biological samples. These chemiluminescent, no-wash assays are ideally suited for miniaturization and ...

Immunoassays have been widely adopted for analysis and quantification of low concentration proteins. The immunoassay is selective and sensitive; however, its utility has been limited in ...

WALTHAM, Mass. – April 4, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to ...

PerkinElmer’s HTRF and AlphaLISA assay kits are designed to detect and quantify CHO host cell protein impurities. PerkinElmer has released two ready-to-use no-wash assay kits in April 2022, the ...

PerkinElmer, Inc. has announced the launch of its AlphaLISA® SureFire® Ultra™ assays. These solutions are designed to reduce assay time by up to 50 percent and to improve the protein phosphorylation ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that a research team at the National Center for Advancing ...

PerkinElmer and BioLegend entered an agreement that allows BioLegend to offer immunoassay development and bioanalytical testing based on PerkinElmer’s AlphaLISA® assay technology. Homogenous ...

The University of Kansas in collaboration with PerkinElmer Inc. worked on looking at the comparison of the AlphaLISA Technology and an Electrochemiluminescence Technology to measure assay windows, ...

Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors WALTHAM, Mass. — PerkinElmer, Inc., a ...

Findings shared on open data portal to help in global pursuit of drug repurposing candidates for COVID-19 The NCATS research project is focused on studying small molecule drug compounds that are ...